Fujicopian Co., Ltd.

7957.T
Business Equipment & Supplies
2026/10/02 18:47 Updated
Market Cap: $21.7M (¥3.4B)
Stock Price: $14.06 (¥2,221)
Exchange Rate: 1 USD = ¥157.98

Notice Regarding Monthly Exercise Status of the 2nd Series Stock Acquisition Rights Allocated to Third Parties (with Exercise Price Adjustment Clause)

Disclosed the monthly exercise status for September 2026 of the 2nd series of stock acquisition rights allocated to third parties. Number of shares underlying the grant: 59,000 shares; 590 rights were exercised during September, representing an exercise ratio of 3.3% of total issued rights. Unexercised rights at month-end: 2,170 rights (217,000 shares); at the end of the prior month: 2,760 rights (276,000 shares). Compliance with exercise restrictions during the period was also disclosed.

Importance:
Page Updated: October 2, 2026
IR Disclosure Date: October 1, 2026

Key Figures

  • Number of shares underlying the grant: 59,000 shares
  • Exercise ratio to total issued rights: 3.3%
  • Unexercised rights at prior month-end: 2,760 rights (276,000 shares)
  • Unexercised rights at month-end: 2,170 rights (217,000 shares)

AI要約

Key Points

Fujicopian Co., Ltd. published the monthly exercise status for September 2026 of the 2nd series of stock acquisition rights allocated to third parties, which were issued on March 10, 2025. Actual exercises in September totaled 590 rights; the number of shares underlying the grant is 59,000 shares, and the exercise ratio to total issued rights is 3.3%. Unexercised rights were 2,760 rights (276,000 shares) at the end of the prior month and 2,170 rights (217,000 shares) at month-end.

Exercise Status and Future Impact

Exercises during the subject month were limited to specific dates within the month (e.g., September 4, September 7, September 24, September 28, September 29, September 30), with the number of shares underlying each grant and the number of rights exercised shown for each date. The total number of listed shares as of the payment date is 1,789,487 shares. Compliance with exercise restrictions is also noted, and dilution remains limited at an exercise ratio of 3.3%. Depending on future movements of unexercised rights, an increase in the number of outstanding shares may occur.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Fujicopian Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →